工作经历
2025-，南京师范大学, 教授
2023.06-，南京大学医学院附属南京市口腔医院，研究员
2019/06-2020/07,WalterandElizaHall Institute of Medical Research ，澳大利亚，访问学者
2017/11-2023.06，南京大学医学院附属南京市口腔医院，副研究员
2017/11-2018/03，澳大利亚昆士兰科技大学，访问学者
2015/01-2017/01，南京大学，医学院，博士后，合作导师：胡勤刚
2011/06-2017/11，南京大学，医学院附属南京市口腔医院，助理研究员
2008/07-2011/05，南京大学，医学院附属南京市口腔医院，研究实习员
荣誉奖励
1.泥艳红(7/11); 口腔癌诊疗关键技术及其应用, 江苏省政府, 科技进步, 省部二等奖, 2018(胡勤刚;杨旭东; 王志勇; 孙国文; 韩伟; 蒲玉梅; 泥艳红; 孙卫斌; 王育新; 鲁勇; 邓润智) (科研奖励)
2.泥艳红(2/7); 慢性炎症微环境影响树突状细胞功能导致口腔鳞癌免疫抑制的系列研究, 南京市人民政府, 科技进步, 其他, 2017(牟永斌; 泥艳红; 黄晓峰; 韩伟; 孙国文; 丁梦; 王南南) (科研奖励)
3.泥艳红 ; Stroma fibroblasts control the Invasion of Oral Squamous Cell Carcinoma, Australia-China Research Symposium 2022, Melbourne, 2022-8-24至2022-8-26 (会议报告)
4.程伟; 胡勤刚; 泥艳红; 李淑媛; 童昕 ; 一种牙科骨替代材料及其制备方法, 2015-12-23, 中国,2918041310122144 (专利)
5.侯亚义; 宋玉仙; 窦环; 泥艳红; 樊竑冶; 赵晓寅 ; 一种外泌体、外泌体的制备方法及其在制备治疗脓毒症药物或者制剂中的应用, 2019-7-23, 中国, ZL201610279473 .9 (专利)
6.侯亚义; 宋玉仙; 泥艳红; 樊竑冶; 赵晓寅; 赵树立 ; 间充质干细胞来源外泌体在制备治疗子痫前期药物或者制剂中的应, 2019-7-23, 中国, ZL201610284313 .3 (专利)
7.孙国文; 蒲玉梅; 王毓佳; 胡勤刚; 泥艳红 ; 一种颈淋巴清扫术后标本固定检出装置, 2016-1-18,中国, 1.ZL201520506339 .9 (专利)
8.蒲玉梅; 孙国文; 王毓佳; 胡勤刚; 泥艳红 ; 一种颈清标本定位板, 2016-1-20, 中国, ZL201520506264 .4 (专利)
9.李淑媛; 朱艳香; 泥艳红; 牟永斌 ; 口腔全景X线摄片定位球的固定装置, 2016-1-13, 中国, ZL201520538595 .6 (专利)
学术任职
第3届中华口腔医学会口腔医学科研管理分会 委员
第3届中华口腔医学会口腔医学科研管理分会 委员
第5届中华口腔医学会口腔生物医学专业委员会 委员
代表性成果
[1] Jin, W., Yu, Q., Yu, L., Zhou, T., Wang, X., Lu, W., Zhang, X., Ding, L., Hu, Q., & Ni, Y. (2025). HAS1high cancer associated fibroblasts located at the tumor invasion front zone promote oral squamous cell carcinoma invasion via ECM remodeling. Journal of experimental & clinical cancer research : CR, 44(1), 238. https://doi.org/10.1186/s13046-025-03493-6
[2] Geng, Y., Liang, Y., Xu, W., Feng, S., Feng, Y., Wan, M., Guan, Y., Ni, Y., & Mao, C. (2025). Application of Nanoformulations in the Treatment of Oral Cancer. Small (Weinheim an der Bergstrasse, Germany), 21(46), e08260. https://doi.org/10.1002/smll.202508260
[3] Si, Q., Wang, Y., Lu, W., Liu, Z., Song, Y., Chen, S., Xia, S., Li, H., Weng, P., Jing, Y., Yu, Q., Zhu, F., Zhang, X., Huang, X., & Ni, Y. (2025). Transferrin receptor uptakes iron from tumor-associated neutrophils to regulate invasion patterns of OSCC. Cancer immunology, immunotherapy : CII, 74(2), 43. https://doi.org/10.1007/s00262-024-03894-0
[4] Wang, Y., Liu, Z., Si, Q., Lu, W., Song, Y., Jin, W., Yang, X., Li, Z., Hu, X., Ding, L., Jing, Y., Weng, P., Yu, Q., O'Reilly, L. A., Silke, J., Zhang, X., Hu, Q., & Ni, Y. (2024). Complex IIa formation and ABC transporters determine sensitivity of OSCC to Smac mimetics. Cell death & disease, 15(11), 855. https://doi.org/10.1038/s41419-024-07253-w
[5] Li, Z., Zhang, X., Li, K., Li, F., Kou, J., Wang, Y., Wei, X., Sun, Y., Jing, Y., Song, Y., Yu, Q., Yu, H., Wang, S., Chen, S., Wang, Y., Xie, S., Zhu, X., Zhan, Y., Sun, G., & Ni, Y. (2024). IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells. Cellular signalling, 117, 111096. https://doi.org/10.1016/j.cellsig.2024.111096
[6] Hu, X., Dong, Y., Xie, S., Song, Y., Yu, C., He, Y., Wang, Z., Hu, Q., Ni, Y., & Ding, L. (2024). Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamous cell carcinoma. The journal of pathology. Clinical research, 10(2), e353. https://doi.org/10.1002/cjp2.353
[7] Zhao, M., He, Y., Zhu, N., Song, Y., Hu, Q., Wang, Z., Ni, Y., & Ding, L. (2023). IL-33/ST2 signaling promotes constitutive and inductive PD-L1 expression and immune escape in oral squamous cell carcinoma. British journal of cancer, 128(5), 833–843. https://doi.org/10.1038/s41416-022-02090-0
[8] Zhang, W., Jing, Y., Wang, S., Wu, Y., Sun, Y., Zhuang, J., Huang, X., Chen, S., Zhang, X., Song, Y., Hu, Q., & Ni, Y. (2022). Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma. Biomolecules, 12(10), 1487. https://doi.org/10.3390/biom12101487
[9] Ding, L., Fu, Y., Zhu, N., Zhao, M., Ding, Z., Zhang, X., Song, Y., Jing, Y., Zhang, Q., Chen, S., Huang, X., O'Reilly, L. A., Silke, J., Hu, Q., & Ni, Y. (2022). OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling. Nature communications, 13(1), 5124. https://doi.org/10.1038/s41467-022-32787-y
[10] Ni, Y., Low, J. T., Silke, J., & O'Reilly, L. A. (2022). Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers. Frontiers in immunology, 13, 835997. https://doi.org/10.3389/fimmu.2022.835997
[11] Wang, Y., Zhang, X., Wang, S., Li, Z., Hu, X., Yang, X., Song, Y., Jing, Y., Hu, Q., & Ni, Y. (2022). Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma. Biomolecules, 12(3), 400. https://doi.org/10.3390/biom12030400
[12] Zhang, D., Song, Y., Li, D., Liu, X., Pan, Y., Ding, L., Shi, G., Wang, Y., Ni, Y., & Hou, Y. (2022). Cancer-associated fibroblasts promote tumor progression by lncRNA-mediated RUNX2/GDF10 signaling in oral squamous cell carcinoma. Molecular oncology, 16(3), 780–794. https://doi.org/10.1002/1878-0261.12935
[13] Sun, Y., Wang, S., Zhang, X., Wu, Z., Li, Z., Ding, Z., Huang, X., Chen, S., Jing, Y., Zhang, X., Ding, L., Song, Y., Sun, G., & Ni, Y. (2021). Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma. Biomolecules, 11(12), 1842. https://doi.org/10.3390/biom11121842
[14] Zhu, N., Zhao, M., Song, Y., Ding, L., & Ni, Y. (2020). The KiSS-1/GPR54 system: Essential roles in physiological homeostasis and cancer biology. Genes & diseases, 9(1), 28–40. https://doi.org/10.1016/j.gendis.2020.07.008
[15] Tan, Y. L., Wu, Z. H., Zhao, B. J., Ni, Y. H., & Dong, Y. C. (2021). For nasotracheal intubation, which nostril results in less epistaxis: right or left?: A systematic review and meta-analysis. European journal of anaesthesiology, 38(11), 1180–1186. https://doi.org/10.1097/EJA.0000000000001462
